Literature DB >> 28791422

Melatonin, mitochondria and hypertension.

Ovidiu C Baltatu1, Fernanda G Amaral2, Luciana A Campos1, Jose Cipolla-Neto3.   

Abstract

Melatonin, due to its multiple means and mechanisms of action, plays a fundamental role in the regulation of the organismal physiology by fine tunning several functions. The cardiovascular system is an important site of action as melatonin regulates blood pressure both by central and peripheral interventions, in addition to its relation with the renin-angiotensin system. Besides, the systemic management of several processes, melatonin acts on mitochondria regulation to maintain a healthy cardiovascular system. Hypertension affects target organs in different ways and cellular energy metabolism is frequently involved due to mitochondrial alterations that include a rise in reactive oxygen species production and an ATP synthesis decrease. The discussion that follows shows the role played by melatonin in the regulation of mitochondrial physiology in several levels of the cardiovascular system, including brain, heart, kidney, blood vessels and, particularly, regulating the renin-angiotensin system. This discussion shows the putative importance of using melatonin as a therapeutic tool involving its antioxidant potential and its action on mitochondrial physiology in the cardiovascular system.

Entities:  

Keywords:  Blood pressure; Cardiovascular system; Hypertension; Melatonin; Mitochondria

Mesh:

Substances:

Year:  2017        PMID: 28791422     DOI: 10.1007/s00018-017-2613-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  149 in total

1.  Locally synthesized angiotensin modulates pineal melatonin generation.

Authors:  Ovidiu Baltatu; Solange Castro Afeche; Sabrina Heloisa José dos Santos; Luciana Aparecida Campos; Roseli Barbosa; Lisete C Michelini; Michael Bader; José Cipolla-Neto
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

2.  Reversible Disruption of Neuronal Mitochondria by Ischemic and Traumatic Injury Revealed by Quantitative Two-Photon Imaging in the Neocortex of Anesthetized Mice.

Authors:  Mikhail Kislin; Jeremy Sword; Ioulia V Fomitcheva; Deborah Croom; Evgeny Pryazhnikov; Eero Lihavainen; Dmytro Toptunov; Heikki Rauvala; Andre S Ribeiro; Leonard Khiroug; Sergei A Kirov
Journal:  J Neurosci       Date:  2017-01-11       Impact factor: 6.167

3.  Angiotensin II augments medullary hypoxia and predisposes to acute renal failure.

Authors:  M Brezis; Z Greenfeld; A Shina; S Rosen
Journal:  Eur J Clin Invest       Date:  1990-04       Impact factor: 4.686

4.  Melatonin protects against isoproterenol-induced alterations in cardiac mitochondrial energy-metabolizing enzymes, apoptotic proteins, and assists in complete recovery from myocardial injury in rats.

Authors:  Debasri Mukherjee; Arnab K Ghosh; Arun Bandyopadhyay; Anjali Basu; Santanu Datta; Sanjib K Pattari; Russel J Reiter; Debasish Bandyopadhyay
Journal:  J Pineal Res       Date:  2012-09       Impact factor: 13.007

Review 5.  Vascular melatonin receptors.

Authors:  M Viswanathan; J T Laitinen; J M Saavedra
Journal:  Biol Signals       Date:  1993 Jul-Aug

6.  p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway.

Authors:  Lin Sun; Li Xiao; Jing Nie; Fu-You Liu; Guang-Hui Ling; Xue-Jing Zhu; Wen-Bin Tang; Wen-Cui Chen; Yun-Cheng Xia; Ming Zhan; Ming-Ming Ma; You-Ming Peng; Hong Liu; Ying-Hong Liu; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-25

Review 7.  Management of hypertension in CKD: beyond the guidelines.

Authors:  Eric Judd; David A Calhoun
Journal:  Adv Chronic Kidney Dis       Date:  2015-03       Impact factor: 3.620

8.  Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.

Authors:  Glenn Marsboom; Peter T Toth; John J Ryan; Zhigang Hong; Xichen Wu; Yong-Hu Fang; Thenappan Thenappan; Lin Piao; Hannah J Zhang; Jennifer Pogoriler; Yimei Chen; Erik Morrow; E Kenneth Weir; Jalees Rehman; Stephen L Archer
Journal:  Circ Res       Date:  2012-04-17       Impact factor: 17.367

9.  Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

Authors:  James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

Review 10.  Mitochondrial Therapies in Heart Failure.

Authors:  Albrecht von Hardenberg; Christoph Maack
Journal:  Handb Exp Pharmacol       Date:  2017
View more
  20 in total

Review 1.  Natural Antioxidants Improve the Vulnerability of Cardiomyocytes and Vascular Endothelial Cells under Stress Conditions: A Focus on Mitochondrial Quality Control.

Authors:  Xing Chang; Zhenyu Zhao; Wenjin Zhang; Dong Liu; Chunxia Ma; Tian Zhang; Qingyan Meng; Peizheng Yan; Longqiong Zou; Ming Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-01-22       Impact factor: 6.543

Review 2.  Hypotensive effects of melatonin in rats: Focus on the model, measurement, application, and main mechanisms.

Authors:  Diana Cvikova; Hana Sutovska; Katarina Babarikova; Lubos Molcan
Journal:  Hypertens Res       Date:  2022-09-20       Impact factor: 5.528

3.  Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease.

Authors:  Yuanzheng Zheng; Saihua Huang; Jialing Zhang; Jia Hou; Fang Wu; Wenji Wang; Xiao Han; Yonghao Gui
Journal:  Cell Prolif       Date:  2022-05-17       Impact factor: 8.755

4.  Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension.

Authors:  Fawad Ali; Arifullah Khan; Syed Aun Muhammad; Syed Qamar Abbas; Syed Shams Ul Hassan; Simona Bungau
Journal:  ACS Omega       Date:  2022-06-20

5.  Aerobic exercise enhanced endothelium-dependent vasorelaxation in mesenteric arteries in spontaneously hypertensive rats: the role of melatonin.

Authors:  Fang Qiu; Xiaodong Liu; Yanyan Zhang; Ying Wu; Daliao Xiao; Lijun Shi
Journal:  Hypertens Res       Date:  2018-07-02       Impact factor: 3.872

Review 6.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

7.  Melatonin Efficacy in Obese Leptin-Deficient Mice Heart.

Authors:  Alessandra Stacchiotti; Gaia Favero; Lorena Giugno; Igor Golic; Aleksandra Korac; Rita Rezzani
Journal:  Nutrients       Date:  2017-12-05       Impact factor: 5.717

Review 8.  Mitochondria: Central Organelles for Melatonin's Antioxidant and Anti-Aging Actions.

Authors:  Russel J Reiter; Dun Xian Tan; Sergio Rosales-Corral; Annia Galano; Xin Jia Zhou; Bing Xu
Journal:  Molecules       Date:  2018-02-24       Impact factor: 4.411

9.  Melatonin Therapy Improves Cardiac Autonomic Modulation in Pinealectomized Patients.

Authors:  Luciana Aparecida Campos; Clarissa Bueno; Isabella P Barcelos; Bruno Halpern; Leandro C Brito; Fernanda G Amaral; Ovidiu Constantin Baltatu; José Cipolla-Neto
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-30       Impact factor: 5.555

Review 10.  Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use.

Authors:  Ovidiu Constantin Baltatu; Sergio Senar; Luciana Aparecida Campos; José Cipolla-Neto
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.